Avance Clinical Revenue and Competitors

Thebarton, USA

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Avance Clinical's estimated annual revenue is currently $63.9M per year.(i)
  • Avance Clinical's estimated revenue per employee is $201,000

Employee Data

  • Avance Clinical has 318 Employees.(i)
  • Avance Clinical grew their employee count by 9% last year.

Avance Clinical's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Head BiostatisticsReveal Email/Phone
3
Head Medical Writing ServicesReveal Email/Phone
4
Head Project Delivery - ANZ & Nth AmericaReveal Email/Phone
5
SVP Scientific and Regulatory AffairsReveal Email/Phone
6
VP, Commercial Business DevelopmentReveal Email/Phone
7
EVP, North American OperationsReveal Email/Phone
8
EVP, North American OperationsReveal Email/Phone
9
VP, Quality AssuranceReveal Email/Phone
10
VP, Compliance & TrainingReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$12252.2M6251111%N/AN/A
#2
$71M300-3%N/AN/A
Add Company

What Is Avance Clinical?

Avance Clinical is a full-service contract research organisation offering a suite of clinical trial services to biotechnology and pharmaceutical companies globally. Our in-house services include: Protocol and Report Writing, Project Management, Site Monitoring, Safety Reporting, Data Management, Statistical Services, Pharmacokinetics, CDISC datasets, QA Consulting/Auditing and Clinical Kit Management. Our team has over 20 years experience in clinical trial services covering a wide range of therapeutic areas across all phases of clinical research. Our client centric philosophy is underpinned by responsiveness, flexibility and results driven accountability. Working in partnership with our clients is paramount in ensuring projects are delivered on time and on budget. Headquartered in South Australia, Avance Clinical has access to a wide network of clinicians and clinical research sites in both Australia and New Zealand. We are well positioned to achieving fast study start times for our clients utilising our deep knowledge of local regulatory requirements. Under the Australian Government?s Research and Development Tax Incentive, clients conducting clinical trials in Australia may be eligible to recover up to 41 cents from every dollar spent on R&D or reduce tax by up to 15%.

keywords:N/A

N/A

Total Funding

318

Number of Employees

$63.9M

Revenue (est)

9%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Avance Clinical News

2022-04-17 - Atossa Therapeutics Announces Completion of Part B of ...

Parts A, B and C of the study are being conducted by Avance Clinical Pty Ltd., a leading Australian clinical research organization.

2022-04-17 - Avance Clinical Finalist for Informa Pharma Intelligence Awards 2022 - Best Contract Research Organizatio

ADELAIDE, AUS, Apr 19, 2022 - (ACN Newswire) - Avance Clinical, the largest premium Australian Contract Research Organisation (CRO) for...

2022-04-17 - Australian Contract Research Organisation (CRO) Avance ...

"Avance Clinical is extremely pleased to be selected as a finalist for this prestigious award. It is a credit to our amazing customer-focused...